A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
A Multicenter, Nonrandomized, Open-Label Phase I/IIClinical Trial to Evaluate the Safety,
Tolerability, and Pharmacokinetics of ICP-723 in Patients with Solid Tumors